FILED AND SPONSOR-REPORTED ETF HOLDINGS
RLAY Included in ETFs
Dates are first observed in retained official snapshots; “baseline” means the security was already present in the earliest retained snapshot and is not an invented original addition date.
Current ETFs holding RLAY
10 latest ETF portfolios currently report this security.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 1.193128% | 2026-01-30 (baseline) | 2026-04-30 |
| CANC | Tema Oncology ETF | 0.911529% | 2025-11-30 (baseline) | 2026-02-28 |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.725548% | 2026-04-30 | 2026-04-30 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.404908% | 2026-04-30 (baseline) | 2026-04-30 |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.372559% | 2026-04-30 | 2026-04-30 |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.195237% | 2026-01-31 (baseline) | 2026-04-30 |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.147494% | 2026-04-30 | 2026-04-30 |
| ISCB | iShares Morningstar Small-Cap ETF | 0.027375% | 2026-01-31 (baseline) | 2026-04-30 |
| GSSC | Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | 0.024641% | 2026-02-28 | 2026-02-28 |
| IWV | iShares Russell 3000 ETF | 0.002451% | 2025-12-31 (baseline) | 2026-03-31 |
Previous ETFs holding RLAY
No previous ETF membership has been observed within the retained snapshot history.